U.S., Feb. 7 -- An application to own the trademark for 'SYNCAN' has been filed on Jan. 03, 2024.
Owner(s):
FRESH CUT DEVELOPMENT, LLC; 4TH FLOOR, 145 ADELAIDE STREET WEST, UNITED STATES
Goods and/or Services:
For: Pharmaceutical preparation for the treatment of epilepsy, Prader-Willi syndrome, obesity, graft versus host disease, gelastic seizures and seizures related to hypothalamic hamartoma, neonatal seizures, movement disorders including dystonia, central pain syndromes, phantom limb pain, multiple sclerosis, traumatic brain injury, injury caused by radiation therapy, acute and chronic graft versus host disease, T-cell autoimmune disorders, colitis, Dravet Syndrome, Lennox Gastaut Syndrome, mycolonic seizures, juvenile mycolonic epi...